Bolt Biotherapeutics (BOLT) Non Operating Income (2020 - 2026)
Bolt Biotherapeutics (BOLT) reported Non Operating Income of $654,000 for Q2 2026, up 0.8% from $649,000 a year earlier and up 83.2% from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Non Operating Income (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bolt Biotherapeutics' Non Operating Income came in at $2.02 million, down 49.0% year-over-year; for FY2025, it came in at $2.74 million, down 72.4% from FY2024.
- By year, Non Operating Income came in at $9.93 million in FY2024 (+41.9%), $7 million in FY2023 (+214.8%), $2.22 million in FY2022 and -$5.8 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income since Q1 2025.
- Year over year, Non Operating Income gained in 1 of the last eight quarters, with an average decline of 49.2%.
- The high point for year-over-year Non Operating Income in five years was Q1 2023 (growth of 624.7%); the low point was Q3 2021 (a decline of 94.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $357,000 (Q1 2026), $454,000 (Q4 2025) and $559,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Bolt Biotherapeutics | 7.09 Mn | 7.09 Mn | - | 654,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 654,000.00 |
| Mar 31, 2026 | 357,000.00 |
| Dec 31, 2025 | 454,000.00 |
| Sep 30, 2025 | 559,000.00 |
| Jun 30, 2025 | 649,000.00 |
| Mar 31, 2025 | 1.08 Mn |
| Dec 31, 2024 | 980,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 6.28 Mn |
| Dec 31, 2023 | 1.86 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.44 Mn |
| Dec 31, 2022 | 1.04 Mn |
| Sep 30, 2022 | 587,000.00 |
| Jun 30, 2022 | 395,000.00 |
| Mar 31, 2022 | 198,000.00 |
| Dec 31, 2021 | -82,000.00 |
| Sep 30, 2021 | 131,000.00 |
API Access
Bolt Biotherapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();